mercredi 17 février 2016

Onco Actu du 17 février 2016

1. Biologie

‘Ecologically diverse’ breast cancers more likely to be deadly [The Institute of Cancer Research]

2.4 Etiologie - Portables, ondes e-m

ABC Catalyst program linking mobile phones to brain cancer 'should never have aired' [The Guardian]

3.6 Prévention - Activité physique

Exercise slows growth of cancer in marathon mice [New Scientist]

4.12 Biopsies liquides

A New Tool in the Toolbox: New Method Traces Free-Floating DNA Back to Its Source [NIH Director's Blog]

5. Traitements

New viral-radiotherapy combination could treat prostate cancers [The Institute of Cancer Research]

Some chemotherapy drugs may increase the percentage of patients whose tumors respond to immune checkpoint therapy [Massachusetts General Hospital]

5.12 Immunothérapies

How to Facilitate Development of Cancer Immunotherapies [ESMO]

5.12.2 Immunothérapies - CAR-T

CAR-T 2.0: Small studies spotlight promise of a breakthrough upgrade [FierceBiotech]

Immunotherapy cancer ‘cure’ headlines distract from fascinating science [Cancer Research UK]

Exciting results in immunotherapy: What do we know? [ACS]

5.2 Pharma

Durvalumab granted Breakthrough Therapy designation by US FDA for treatment of patients with PD-L1 positive urothelial bladder cancer [AstraZeneca]

New Drug Ads Tout Serious Conditions, Costly Treatments [Wall Street Journal]

5.2.1 Pharma - Partenariats

BIND Therapeutics and Synergy Pharmaceuticals Announce Collaboration to Develop ACCURINS® with Proprietary Uroguanylin Analogs for Targeting Gastrointestinal Receptors on Tumors [BIND Therapeutics]

Bristol-Myers Squibb and Dana-Farber Cancer Institute Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program [BMS]

5.4 Traitements - Economie

Couple to Give $7.2 Million Toward Efforts to Lower Drug Prices [Wall Street Journal]

6.1 Observation

Cancer cases rise in UK, says charity [BBC News]

Cancer rates up 12% in 20 years, say Cancer Research UK [The Guardian]

6.6 Publications

Seralini paper released by predatory publisher is plagiarized by predatory journal [Retraction Watch]

6.7 DMP, Big Data & applis

Hear CancerLinQ LLC CEO Discuss Using Big Data to Personalize Patient Care in February 18 Webinar [ASCO]